Definitive Contract W911QX13C0069

This is a SBIR Phase I contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), which is part of the Department of Health and Human Services (HHS), to Nanocomposix, Inc., a small business manufacturer of engineered nanoparticles. The contract has a firm fixed price of $300,000.00 and is for the development of a point-of-care test to measure antibiotic concentrations in the blood for tuberculosis (TB) treatment. Nanocomposix has prior experience providing products...

Nanocomposix, Inc. was awarded a $300,000 firm fixed price Small Business Innovation Research Phase I contract from the National Institutes of Health's National Institute of Allergy and Infectious Diseases. This contract is in response to a solicitation seeking proposals for research and development of alternatives to cell culture materials, cancer immunotherapy manufacturing methods, and other biomedical technologies. Specifically, Nanocomposix will design and synthesize a new PLGA-based...

The Department of Health and Human Services National Institutes of Health National Heart Lung and Blood Institute awarded a $19.3 million firm fixed price definitive contract to ANP Technologies Inc. to support the RADX TECH PROJECT #2620 for accelerated manufacturing scale-up of ANP Technologies' nano-intelligent detection system for COVID-19 antigen rapid testing. Performance will take place in Newark, Delaware over a two year period concluding in December 2022. No set aside designation or...

This is a $1,099,988.88 firm fixed-price contract awarded by the U.S. Army's Research, Development and Engineering Command (DEVCOM) to Parabon NanoLabs, Inc., a small business, on July 11, 2022. The contract is for the development and demonstration of a novel, innovative nanoantibiotics platform to design and synthesize nanocarriers able to effectively deliver antimicrobial peptides to lung tissue to treat pulmonary infections from aerosolized biothreat agents. This contract is part of the...

This is a Small Business Innovation Research (SBIR) Phase II contract awarded by the U.S. Army Research, Development and Engineering Command (RDECOM) to ANP Technologies Inc., a minority-owned for-profit small business located in Newark, Delaware. The $1,599,533 firm-fixed-price contract will develop rapid, heat-stable handheld lateral flow immunoassays utilizing thermally stable recombinant proteins and nano-intelligent detection system technology to quickly detect various biological targets....

This is a $225,000.00 Small Business Innovation Research (SBIR) Program Phase I contract awarded by the National Institutes of Health (NIH) National Institute of Allergy and Infectious Diseases to Nanocomposix, Inc., a manufacturer of engineered nanoparticles. The contract is for the development of "TOPIC 59 DIAGNOSTICS TO ENABLE MALARIA AND NEGLECTED TROPICAL DISEASES". Nanocomposix has previously provided lateral flow assay devices, gold nanoparticles, and research and development...

<p>This is a $149,500.00 Firm Fixed Price contract awarded by the Defense Advanced Research Projects Agency (DARPA) to Nanomedical Diagnostics, Inc., a small business manufacturer, under the Small Business Innovation Research (SBIR) Program Phase I. The contract is for the &quot;REAL-TIME ASSESSMENT OF ANTIMICROBIAL CONCENTRATIONS FOR PERSONALIZED TREATMENT OF INFECTIOUS DISEASES.&quot; The contract was awarded on October 24, 2016 with a final completion date of July 23, 2017.</p>

This is a $1,100,000.00 Small Business Innovation Research (SBIR) Phase II contract awarded by the U.S. Army Research, Development and Engineering Command (RDECOM) to Parabon Nanolabs, Inc. The contract is for &quot;Origami Antibodies for Threat Sensing&quot;, which involves research and development of novel systems leveraging DNA nanotechnology for applications such as sensing, vaccines, drug delivery, and gene therapy. Parabon Nanolabs is a company that specializes in engineering DNA for...

This contract was awarded by the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH), to Southern Research Institute, a nonprofit research organization. The contract is for in vitro assessments of antimicrobial activity, under a larger NIAID indefinite delivery/indefinite quantity (IDIQ) contract vehicle for antimicrobial drug development services. The fixed-price contract has a ceiling value of $67,100 and a period of performance...

<p>The National Institute of Allergy and Infectious Diseases (NIAID) awarded a $224,881.00 Firm Fixed Price contract to Keystone Nano Inc., a Small Disadvantaged Business, for the &quot;DEVELOPMENT OF SIRNA NANOJACKETS FOR RNAI-BASED INFLUENZA TREATMENT&quot; under the Small Business Innovation Research (SBIR) Program Phase I. The contract has a completion date of January 31, 2017. This award is a Definitive Contract and is set aside for small business.</p>